Details
Stereochemistry | ACHIRAL |
Molecular Formula | C13H19NO4S |
Molecular Weight | 285.359 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
CCCN(CCC)S(=O)(=O)C1=CC=C(C=C1)C(O)=O
InChI
InChIKey=DBABZHXKTCFAPX-UHFFFAOYSA-N
InChI=1S/C13H19NO4S/c1-3-9-14(10-4-2)19(17,18)12-7-5-11(6-8-12)13(15)16/h5-8H,3-4,9-10H2,1-2H3,(H,15,16)
Molecular Formula | C13H19NO4S |
Molecular Weight | 285.359 |
Charge | 0 |
Count |
|
Stereochemistry | ACHIRAL |
Additional Stereochemistry | No |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Optical Activity | NONE |
Approval Year
Substance Class |
Chemical
Created
by
admin
on
Edited
Fri Dec 15 15:21:18 UTC 2023
by
admin
on
Fri Dec 15 15:21:18 UTC 2023
|
Record UNII |
PO572Z7917
|
Record Status |
Validated (UNII)
|
Record Version |
|
-
Download
Name | Type | Language | ||
---|---|---|---|---|
|
Official Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Brand Name | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C921
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
||
|
LIVERTOX |
NBK548599
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
||
|
WHO-ATC |
M04AB01
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
||
|
WHO-VATC |
QM04AB01
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
PO572Z7917
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | |||
|
4357
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | |||
|
Probenecid
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | |||
|
3387
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | |||
|
m9142
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | Merck Index | ||
|
SUB10053MIG
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | |||
|
CHEMBL897
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | |||
|
DTXSID9021188
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | |||
|
Probenecid
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | |||
|
57-66-9
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | |||
|
1563003
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | |||
|
2268
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | |||
|
D011339
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | |||
|
18786
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | |||
|
8698
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | RxNorm | ||
|
100000081091
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | |||
|
PROBENECID
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | Description: A white or almost white, crystalline powder; odourless. Solubility: Practically insoluble in water; soluble in 25 parts of ethanol (~750 g/l) TS and in 12 parts of acetone R; soluble in dilutesolutions of alkali hydroxides. Category: Antigout drug. Storage: Probenecid should be kept in a well-closed container. Definition: Probenecid contains not less than 98.0% and not more than 101.0% of C13H19NO4S, calculated with reference to thedried substance. | ||
|
PO572Z7917
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | |||
|
8426
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | |||
|
563
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | |||
|
DB01032
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | |||
|
C772
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | |||
|
200-344-3
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY | |||
|
4911
Created by
admin on Fri Dec 15 15:21:18 UTC 2023 , Edited by admin on Fri Dec 15 15:21:18 UTC 2023
|
PRIMARY |
Related Record | Type | Details | ||
---|---|---|---|---|
|
TRANSPORTER -> INHIBITOR | |||
|
TRANSPORTER -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
||
|
TARGET -> INHIBITOR |
|
||
|
TRANSPORTER -> INHIBITOR | |||
|
TARGET -> INHIBITOR |
Primary target.
|
||
|
SALT/SOLVATE -> PARENT | |||
|
TRANSPORTER -> INHIBITOR |
|
||
|
TRANSPORTER -> INHIBITOR | |||
|
TRANSPORTER -> INHIBITOR | |||
|
TRANSPORTER -> SUBSTRATE |
Related Record | Type | Details | ||
---|---|---|---|---|
|
METABOLITE -> PARENT | |||
|
METABOLITE -> PARENT |
|
||
|
METABOLITE -> PARENT |
Related Record | Type | Details | ||
---|---|---|---|---|
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
||
|
IMPURITY -> PARENT |
CHROMATOGRAPHIC PURITY (HPLC/UV)
EP
|
Related Record | Type | Details | ||
---|---|---|---|---|
|
ACTIVE MOIETY |